In 2023, healthcare expenditure on prescribed medicines in France stood at 32.60 billion Euros. Forecasted data from 2024 to 2028 shows a consistent year-on-year increase in spending, with values ranging from 32.89 billion Euros to 34.01 billion Euros. The year-on-year growth rates are as follows: 0.89% from 2024 to 2025, 0.84% from 2025 to 2026, 0.84% from 2026 to 2027, and 0.80% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the five-year period (2023-2028) is approximately 0.86%, indicating a steady upward trend in expenditure.
Future trends to watch for include potential impacts from policy changes, advances in medical technology, shifts towards generic medications, and the financial implications of an aging population. Monitoring these factors will be crucial in predicting future healthcare expenditure patterns.
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
